IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Genzyme Sells Pharma Intermediates Business to ICIG

11:18 AM MST | March 9, 2011 | Deepti Ramesh

Biotechnology company Genzyme (Cambridge, MA) says it has completed the sale of its pharmaceutical intermediates business to the International Chemical Investors Group (ICIG; Frankfurt). Financial terms of the deal were not disclosed. ICIG purchased all of the pharmaceutical intermediates business, excluding the drug delivery technologies unit. The acquired business has been renamed Corden Pharma Switzerland and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma group. The Corden Pharma group is the pharmaceutical market...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa